Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study) [Phase 1, Phase 2]

View source ↗

Summary

Initial safety results from the TRUE AVC device for hemodialysis access were reported from Phase 1/2 trials in patients with end-stage renal disease; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vascudyne, Inc. | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: COMPLETED